Instil Bio, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $508.6M | $61.5M |
| Jun 2022 | — | $458.3M | $42.5M |
| Sep 2022 | — | $410.6M | $41.1M |
| Dec 2022 | — | $363.6M | $43.7M |
| Mar 2023 | — | $311.2M | $27.4M |
| Jun 2023 | — | $296.5M | $21.8M |
| Sep 2023 | — | $234.0M | $9.1M |
| Dec 2023 | — | $225.8M | $9.2M |
| Mar 2024 | — | $205.8M | $5.5M |
| Jun 2024 | — | $195.0M | $6.8M |
| Sep 2024 | — | $176.3M | $6.7M |
| Dec 2024 | — | $169.4M | $8.8M |
| Mar 2025 | — | $144.9M | $15.4M |
| Jun 2025 | — | $131.7M | $7.7M |
| Sep 2025 | — | $120.4M | $5.8M |
| Dec 2025 | — | $113.9M | $6.6M |
| Mar 2026 | — | $110.7M | $5.0M |
| Jun 2026 | — | $107.4M | $5.5M |